You are here: Industry Insights > Medicago

News List

GSK partners with Medicago to develop plant-based Covid-19 vaccine pharmaceutical-technology
July 08, 2020
GlaxoSmithKline (GSK) has partnered with Canadian biopharmaceutical firm Medicago to develop, assess and manufacture a plant-based adjuvanted Covid-19 vaccine candidate.
Medicago announces production of a viable vaccine candidate for COVID-19 expresspharma
March 27, 2020
The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease.
Medicago produces viable Covid-19 vaccine candidate pharmaceutical-technology
March 16, 2020
Biopharmaceutical firm Medicago has produced a Virus-Like Particle (VLP) of the novel coronavirus, marking the first step in Covid-19 vaccine development.
Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine americanpharmaceuticacreview
September 27, 2017
Medicago announced the start of a Phase 3 efficacy study for its seasonal quadrivalent influenza vaccine (QIV) candidate.

Previous page 1 2 Next page